4//SEC Filing
WEISSKOFF ROBERT 4
Accession 0001179110-04-019123
CIK 0001027702other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:33 PM ET
Size
8.9 KB
Accession
0001179110-04-019123
Insider Transaction Report
Form 4
WEISSKOFF ROBERT
VP of Business DevelopOther
Transactions
- Sale
Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)
2004-09-29$19.45/sh−1,000$19,450→ 0 total - Exercise/Conversion
Common Stock
2004-09-29$8.50/sh+1,000$8,500→ 1,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2004-09-29$8.50/sh−1,000$8,500→ 15,504 totalExercise: $8.50From: 2002-01-02Exp: 2011-01-02→ Common Stock (1,000 underlying)
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 4, 2003.
- [F2]From January 2, 2001 grant of 35,000 options to purchase shares of common stock of which 19,054 options have been exercised, 1,504 options are currently exercisable and the remaining 14,000 options vest in 2 equal installments beginning on January 2, 2005.
Documents
Issuer
EPIX Pharmaceuticals, Inc.
CIK 0001027702
Entity typeother
Related Parties
1- filerCIK 0001239299
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 4:33 PM ET
- Size
- 8.9 KB